Tate & Lyle’s SODA-LO™ Salt Microspheres "Most Innovative Health Ingredient of the Year" at NuW Excellence Awards 2012

| Filed in:

14 November, 2012 – Tate & Lyle’s ground-breaking, new salt-reduction ingredient, SODA-LO™ Salt Microspheres, was recognized as the "Heart Health and Circulatory Innovation of the Year" and as the overall "Most Innovative Health Ingredient of the Year" from the NuW Excellence Awards, which recognize individuals and business for their exemplary work and contribution to the industry.

"We are proud that a jury of experts recognized both the relevance of SODA-LOSalt Microspheres in today’s public health environment and the potential extraordinary value that it delivers to food manufacturers," said Andy Hoffman, Director of Health and Wellness Innovation, Tate & Lyle.

SODA-LO™ Salt Microspheres is a salt reduction ingredient that tastes, labels and functions like salt because it is salt. SODA-LO™ Salt Microspheres reduces salt levels by 25 to 50 percent in various applications including baked goods and salty snacks. SODA-LO™ Salt Microspheres has been created using a patent-pending technology that turns standard salt crystals into free-flowing crystalline microspheres. These smaller, lower-density crystals efficiently deliver salty taste by maximizing surface area relative to volume.

"The development of SODA-LO Salt Microspheres is a true case study in innovation helping to overcome a challenge – in this case reducing salt while maintaining taste – and we couldn’t be happier with the results and the commendation from NuW Excellence Awards," said Hoffman.

The winners of the categories were announced at the Messe Frankfurt where the Health Ingredients Europe is taking place until the 15th November 2012. Close to 40 entries were received into the awards with submissions coming from mainland Europe, Taiwan, China and the United States. The NuW Excellence Awards jury panel consisted of 9 leaders in the finished foods, beverages and ingredients industry.

About SODA-LO™ Salt Microspheres: A salt reduction ingredient, SODA-LO™ Salt Microspheres tastes, labels and functions like salt because it is salt. Tate & Lyle licensed SODA-LO® from Eminate Ltd, a wholly owned subsidiary of The University of Nottingham, UK, to commercialize it globally. Under the license agreement, Tate & Lyle assumes responsibility for commercialising the SODA-LO® salt reduction technology on a global basis including manufacturing, product development, sales and marketing. About Health Ingredients Europe & NuW Health ingredients Europe is part of the world-leading Food Ingredients, Natural Ingredients and Health Ingredients series of ingredients trade shows. These highly professional trade shows have been held successfully since 1986. Health ingredients Europe was launched in 2000 with Hi Europe (NuW) 2012 being the 7th edition of this show. Health Ingredients Europe will be joining NuW Nutrition + Wellness Solutions in 2012, creating a new exhibition that provides a complete 360-degree perspective of the entire nutrition and wellness industry. For more information, visit http://www.nuwsolutions.com About UBM plc UBM plc is a leading global company. We inform markets and bring the world's buyers and sellers together at events, online, in print and provide them with the information they need to do business successfully. We focus on serving professional commercial communities, from doctors to game developers, from journalists to jewellery traders, and from farmers to pharmacists around the world. Our 6,600 staff in more than 31 countries are organised into specialist teams that serve these communities, helping them to do business effectively and efficiently.

About Tate & Lyle: 
Tate & Lyle PLC is a leading global provider of food and beverage ingredients and solutions. Supported by our 160-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients every day.

Through our expertise in sweetening, mouthfeel and fibre fortification, our Food & Beverage Solutions business develops solutions which reduce sugar, calories and fat, add fibre, and provide texture and stability in categories including beverages, dairy, bakery, soups, sauces and dressings. Our Primary Products business produces nutritive sweeteners, industrial starches used in paper and packaging, acidulants and products used for animal nutrition.

We have around 4,500 employees working in more than 60 locations across 30 countries. Tate & Lyle’s purpose is Improving Lives for Generations and through our purpose we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2020, Tate & Lyle sales totalled £2.9 billion. For more information, please visit http://www.tateandlyle.com or follow Tate & Lyle on TwitterLinkedin or Facebook.